Know HBV 1.5.2

The Chronic Hepatitis B Treatment Decision Tool for Adults, developed by the Asian Liver Center at Stanford University, addresses the WHO Global Health Sector Strategy on Viral Hepatitis. Its primary goal is to enhance treatment rates to at least 80% by 2030 when indicated. This application serves as an educational resource designed specifically for primary healthcare professionals, particularly in resource-limited settings. It offers a general framework for monitoring adults who test positive for HBsAg and outlines scenarios in which antiviral treatment may be recommended, based on guidelines adapted from the World Health Organization and the American Association for the Study of Liver Diseases.

It is important to note that this app is intended to provide general guidance and is not a substitute for specialist consultations regarding liver disease and chronic hepatitis management. Recommendations made within the tool should never replace a comprehensive evaluation of the patient’s condition and any relevant contraindications. Healthcare professionals are encouraged to inform patients about the facts surrounding hepatitis B, as well as the potential benefits and risks associated with antiviral treatments. This app is strictly for use by healthcare professionals; it is not designed for patient use. Individuals seeking medical advice should consult a physician prior to making any healthcare decisions.